Open Access

Clinical significance of sCD163 and its possible role in asthma (Review)

  • Authors:
    • Yue Zhi
    • Peng Gao
    • Xiuqin Xin
    • Wei Li
    • Lei Ji
    • Lin Zhang
    • Xueyang Zhang
    • Jie Zhang
  • View Affiliations

  • Published online on: March 24, 2017     https://doi.org/10.3892/mmr.2017.6393
  • Pages: 2931-2939
  • Copyright: © Zhi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Macrophages exert important functions in the balance and efficiency of immune responses, and participate in innate and adaptive immunity. The proinflammatory actions of macrophages are implicated in autoimmune diseases. Unlike classically activated M1 macrophages, the alternatively activated cluster of differentiation (CD)163+ and CD206+ M2 macrophages are involved in tissue repair and wound healing, and use oxidative metabolism to support their long‑term functions. CD163 is a member of the scavenger receptor superfamily, categorized into class B, and its soluble(s) form, sCD163, is a marker of activated M2 macrophages. CD163 is selectively expressed in cells of the monocyte and macrophage lineages; however, its biological role has yet to be elucidated. The expression of sCD163 is markedly induced by anti‑inflammatory mediators, such as glucocorticoids and interleukin‑10, whereas it is inhibited by proinflammatory mediators, such as interferon‑γ. These findings suggest that CD163 may serve as a potential target for the therapeutic modulation of inflammatory responses. The concentration of sCD163 in blood is associated with acute and chronic inflammatory processes in autoimmune disorders of connective tissue, fat metabolism and cardiovascular diseases, and it can be used for the assessment of cancer prognosis. A role for sCD163 in the pathogenesis of asthma has also been proposed. The present review serves to present the available knowledge concerning the implication of sCD163 in the pathophysiological mechanisms of asthma, and evaluate its potential as a biomarker and possible therapeutic target for asthma.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 15 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhi Y, Gao P, Xin X, Li W, Ji L, Zhang L, Zhang X and Zhang J: Clinical significance of sCD163 and its possible role in asthma (Review). Mol Med Rep 15: 2931-2939, 2017
APA
Zhi, Y., Gao, P., Xin, X., Li, W., Ji, L., Zhang, L. ... Zhang, J. (2017). Clinical significance of sCD163 and its possible role in asthma (Review). Molecular Medicine Reports, 15, 2931-2939. https://doi.org/10.3892/mmr.2017.6393
MLA
Zhi, Y., Gao, P., Xin, X., Li, W., Ji, L., Zhang, L., Zhang, X., Zhang, J."Clinical significance of sCD163 and its possible role in asthma (Review)". Molecular Medicine Reports 15.5 (2017): 2931-2939.
Chicago
Zhi, Y., Gao, P., Xin, X., Li, W., Ji, L., Zhang, L., Zhang, X., Zhang, J."Clinical significance of sCD163 and its possible role in asthma (Review)". Molecular Medicine Reports 15, no. 5 (2017): 2931-2939. https://doi.org/10.3892/mmr.2017.6393